VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $72,627,000 | -61.9% | 714,485 | -33.2% | 0.46% | -61.5% |
| Q3 2015 | $190,787,000 | -5.9% | 1,069,555 | +17.3% | 1.20% | +2.6% |
| Q2 2015 | $202,643,000 | -6.0% | 912,189 | -15.9% | 1.17% | -2.7% |
| Q1 2015 | $215,552,000 | +22.3% | 1,085,248 | -11.9% | 1.20% | +36.1% |
| Q4 2014 | $176,221,000 | +5.1% | 1,231,368 | -3.7% | 0.88% | +16.4% |
| Q3 2014 | $167,745,000 | -0.2% | 1,278,544 | -4.1% | 0.76% | +13.0% |
| Q2 2014 | $168,087,000 | -4.1% | 1,332,754 | +0.3% | 0.67% | -2.9% |
| Q1 2014 | $175,232,000 | -15.2% | 1,329,230 | -24.5% | 0.69% | -12.5% |
| Q4 2013 | $206,698,000 | +12.7% | 1,760,631 | +0.2% | 0.79% | +6.8% |
| Q3 2013 | $183,355,000 | +13.4% | 1,757,453 | -6.5% | 0.74% | +0.1% |
| Q2 2013 | $161,740,000 | – | 1,878,950 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |